RS44004A - Processes for the preparation of substituted bicyclid derivatives for the treatment of abnormal cell growth - Google Patents

Processes for the preparation of substituted bicyclid derivatives for the treatment of abnormal cell growth

Info

Publication number
RS44004A
RS44004A YU44004A YUP44004A RS44004A RS 44004 A RS44004 A RS 44004A YU 44004 A YU44004 A YU 44004A YU P44004 A YUP44004 A YU P44004A RS 44004 A RS44004 A RS 44004A
Authority
RS
Serbia
Prior art keywords
processes
cell growth
abnormal cell
bicyclid
derivatives
Prior art date
Application number
YU44004A
Other languages
English (en)
Inventor
Davod Harold Brown Ripin
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of RS44004A publication Critical patent/RS44004A/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/027—Organoboranes and organoborohydrides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pronalazak se odnosi na postupke za dobijanje jedinjenja formule (1) i njegove farmaceutski prihvatljie soli, prolekove i solvate, gde su R1, R2, R4, R5, R11, m i p kao što je ovde definisano. Jedinjenja formule (1) su korisni u lečenju abnormalnog rasta ćelija kod sisara, administriranjem farmaceutskih preparata.
YU44004A 2001-11-30 2002-10-03 Processes for the preparation of substituted bicyclid derivatives for the treatment of abnormal cell growth RS44004A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33464701P 2001-11-30 2001-11-30
PCT/IB2002/004097 WO2003045939A1 (en) 2001-11-30 2002-10-03 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth

Publications (1)

Publication Number Publication Date
RS44004A true RS44004A (en) 2006-10-27

Family

ID=23308141

Family Applications (1)

Application Number Title Priority Date Filing Date
YU44004A RS44004A (en) 2001-11-30 2002-10-03 Processes for the preparation of substituted bicyclid derivatives for the treatment of abnormal cell growth

Country Status (28)

Country Link
US (1) US20030144506A1 (sr)
EP (1) EP1448551B1 (sr)
JP (1) JP4220388B2 (sr)
KR (1) KR20040054813A (sr)
CN (1) CN1639149A (sr)
AR (1) AR037591A1 (sr)
AT (1) ATE377009T1 (sr)
AU (1) AU2002337428A1 (sr)
BR (1) BR0214606A (sr)
CA (1) CA2462149C (sr)
DE (1) DE60223279T2 (sr)
DO (1) DOP2002000519A (sr)
ES (1) ES2295409T3 (sr)
GT (1) GT200200245A (sr)
HN (1) HN2002000334A (sr)
HU (1) HUP0500117A3 (sr)
IL (1) IL160971A0 (sr)
MX (1) MXPA04005157A (sr)
PA (1) PA8558601A1 (sr)
PE (1) PE20030643A1 (sr)
PL (1) PL370911A1 (sr)
RS (1) RS44004A (sr)
RU (1) RU2004116345A (sr)
SV (1) SV2004001419A (sr)
TN (1) TNSN02096A1 (sr)
TW (1) TW200300691A (sr)
WO (1) WO2003045939A1 (sr)
ZA (1) ZA200402054B (sr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003303045A1 (en) * 2002-12-18 2004-07-09 Pfizer Products Inc. 4-anilino quinazoline derivatives for the treatment of abnormal cell growth
BR0317259A (pt) * 2002-12-19 2005-11-08 Pfizer Prod Inc Complexos de e-2-metóxi-n-(3-{4-[3-metil-4-(6-metilpiridin-3-ilóxi)-fenil amino]- quinazolin-6-il}-alil)-acetamida, seus métodos de produção e utilização
RU2005125607A (ru) * 2003-04-09 2006-03-27 Пфайзер Продактс Инк. (Us) Способы получения производных n(пиридинилокси)-фениламино)хиназолинил)аллил)ацетамида и родственных соединений, а также промежуточные соединения для таких способов и способы получения таких соединений
US7618975B2 (en) * 2003-07-03 2009-11-17 Myriad Pharmaceuticals, Inc. 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
WO2006074147A2 (en) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
US20050192298A1 (en) * 2004-02-27 2005-09-01 Pfizer Inc Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide
UA85706C2 (en) * 2004-05-06 2009-02-25 Уорнер-Ламберт Компани Ллси 4-phenylaminoquinazolin-6-yl amides
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2635837A1 (en) * 2005-12-02 2007-06-28 The Paper Products Limited Holographic flexible tube laminate for packaging and method of making the same
MX2021003517A (es) 2018-09-25 2021-08-16 Black Diamond Therapeutics Inc Composiciones de inhibidor de tirosina quinasa, metodos de fabricacion y metodos de uso.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW321649B (sr) * 1994-11-12 1997-12-01 Zeneca Ltd
DE19501481A1 (de) * 1995-01-19 1996-07-25 Bayer Ag 2,8-Disubstituierte Chinazolinone
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
HUP0301120A2 (hu) * 2000-06-22 2003-08-28 Pfizer Products Inc. Szubsztituált fenilamino-kinazolin-származékok, alkalmazásuk rendellenes sejtnövekedés kezelésére és azokat tartalmazó gyógyszerkészítmények

Also Published As

Publication number Publication date
SV2004001419A (es) 2004-02-24
JP2005515986A (ja) 2005-06-02
TW200300691A (en) 2003-06-16
DE60223279T2 (de) 2008-05-29
PE20030643A1 (es) 2003-07-23
ES2295409T3 (es) 2008-04-16
DOP2002000519A (es) 2003-05-31
MXPA04005157A (es) 2004-08-11
US20030144506A1 (en) 2003-07-31
EP1448551B1 (en) 2007-10-31
IL160971A0 (en) 2004-08-31
HN2002000334A (es) 2003-02-21
JP4220388B2 (ja) 2009-02-04
PA8558601A1 (es) 2003-06-30
CA2462149C (en) 2010-06-22
AR037591A1 (es) 2004-11-17
DE60223279D1 (de) 2007-12-13
HUP0500117A3 (en) 2008-03-28
KR20040054813A (ko) 2004-06-25
PL370911A1 (en) 2005-05-30
WO2003045939A1 (en) 2003-06-05
EP1448551A1 (en) 2004-08-25
RU2004116345A (ru) 2005-03-27
CN1639149A (zh) 2005-07-13
CA2462149A1 (en) 2003-06-05
AU2002337428A1 (en) 2003-06-10
ATE377009T1 (de) 2007-11-15
HUP0500117A2 (hu) 2005-05-30
BR0214606A (pt) 2004-09-14
TNSN02096A1 (en) 2005-12-23
ZA200402054B (en) 2005-05-23
GT200200245A (es) 2003-09-24

Similar Documents

Publication Publication Date Title
YU95102A (sh) Supstituisani biciklični derivati u lečenju abnormalnog rasta ćelija
MXPA05006420A (es) Derivados de pirimidina para el tratamiento de crecimiento celular anormal.
YU30702A (sh) Novi derivati benzoimidazola, korisni agensi protiv proliferacije
RS20050180A (en) Novel benzoimidazole derivatives useful as antiproliferative agensts
MY124390A (en) Substituted bicyclic derivatives useful as anticancer agents
GT199900139A (es) Derivados de quinolin-2-ona ùtiles como agentes contra el càncer.
ATE260263T1 (de) Heteroaromatische bizyklische verbindungen mit antikrebswirkung
AP2001002079A0 (en) Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents.
BG104998A (en) Isothiazole derivatives useful as anticancer agents
MXPA04000577A (es) Derivados de dolastatina 10.
WO2006067614A3 (en) Heteroaromatic derivatives useful as anticancer agents
MX2007004183A (es) Derivados de benzoimidazol utiles como agentes antiproliferacion.
AP2001002302A0 (en) 13-Methyl erythromycin derivatives.
RS44004A (en) Processes for the preparation of substituted bicyclid derivatives for the treatment of abnormal cell growth
DE69734678D1 (de) 6-0-substitutierte eryththromycin-verbindungen und verfahrenen zu ihrer herstellung
AP2002002494A0 (en) Hygromycin derivatives.
CA2352332A1 (en) Hygromycin a derivatives
MXPA02011966A (es) Derivados de higromicina a para el el tratamiento de infecciones bacterianas y por protozoarios.
AP2002002492A0 (en) Hygromycin a prodrugs.